2001
DOI: 10.1097/00007890-200108150-00017
|View full text |Cite
|
Sign up to set email alerts
|

Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation1

Abstract: Optimizing the management of brain-dead organ donors, including the possibility of selective administration of adrenergic agents, may provide a major benefit on graft survival without adverse side effects for the recipients. Further investigation on best use of adrenergic drugs, optimum dosage, and duration is warranted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
96
0
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 155 publications
(103 citation statements)
references
References 70 publications
6
96
0
1
Order By: Relevance
“…Norepinephrine was used because it is the (4). Similarly high rates of catecholamine administration have been reported in other registries such as the Eurotransplant registry, where 91% of brain-dead donors were maintained with catecholamines and one-third donors receiving more than one catecholamine infusion (33).…”
Section: Discussionsupporting
confidence: 69%
“…Norepinephrine was used because it is the (4). Similarly high rates of catecholamine administration have been reported in other registries such as the Eurotransplant registry, where 91% of brain-dead donors were maintained with catecholamines and one-third donors receiving more than one catecholamine infusion (33).…”
Section: Discussionsupporting
confidence: 69%
“…Very high doses of catecholamines administered to experimental animals have induced damage to the myocardium similar to the changes induced by the sympathetic storm during brain death, [9][10][11] and the use of norepinephrine to donors has been related to primary nonfunction in heart transplantation. 87 This has led to high numbers of donors refused by cardiac surgeons exclusively due to the doses of catecholamines used. 88 However, excellent outcomes have been reported in heart transplant recipients from donors managed with high doses of dopamine and norepinehrine 89 and, as discussed previously, restoring the loading conditions of the heart after loss of sympathetic tone is essential for maintaining and improving cardiac performance after brain death.…”
Section: Hemodynamic Managementmentioning
confidence: 99%
“…Vasopressin is effective against diabetes insipidus, and it reduces the hemodynamic need for catecholamines. 101,102 In addition to the association with primary nonfunction, 87 norepinephrine has been related to reduced right ventricular contractility and reduced 1-year survival in heart transplantation. 104 However, these data are retrospective, and no causal connection between norepinephrine and outcome has been demonstrated.…”
Section: Hemodynamic Managementmentioning
confidence: 99%
“…There is some evidence supporting dopamine as a first choice inotrope, in doses of less than 10 mcg/kg/min. The same analysis found that norepinephrine administration was associated with an increased incidence of cardiac graft failure, but similar negative effect was not observed with dopamine, dobutamine, and epinephrine [14]. In addition to the improved oxygen delivery, there are further possible explanations for the salutary effects of adrenergic drugs.…”
Section: Donor Managementmentioning
confidence: 88%